The ICN2 spin-off will collaborate with this prestigious US medical foundation and hospital to further develop its graphene Brain-Computer Interfaces (BCI) for the treatment of neurological disorders.
The ICN2 spin-off will collaborate with this prestigious US medical foundation and hospital to further develop its graphene Brain-Computer Interfaces (BCI) for the treatment of neurological disorders.